These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 113879)

  • 1. Current concepts in the management of patients with deeply invasive bladder carcinoma.
    Cummings KB; Shipley WU; Einstein AB; Cutler SJ
    Semin Oncol; 1979 Jun; 6(2):220-8. PubMed ID: 113879
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolving concepts in muscle-invasive bladder cancer.
    Black PC; Kassouf W
    World J Urol; 2016 Jan; 34(1):1-2. PubMed ID: 26743671
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic options and treatment of muscle invasive bladder cancer.
    O'Connor RC; Alsikafi NF; Steinberg GD
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):511-22. PubMed ID: 12113083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ conservation in deeply invasive bladder cancer.
    Fair WR
    Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
    [No Abstract]   [Full Text] [Related]  

  • 5. Bladder cancer.
    Leung HY; Griffiths TR; Neal DE
    Postgrad Med J; 1996 Dec; 72(854):719-24. PubMed ID: 9015464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscle-invasive bladder cancer].
    Pashootan P; Legrand G; Ploussard G
    Rev Prat; 2014 Dec; 64(10):1391-2, 1395-8. PubMed ID: 25668831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives in the management of high-grade invasive bladder cancer.
    Skinner DG
    Cancer; 1980 Apr; 45(7 Suppl):1866-74. PubMed ID: 7370937
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
    Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16 years experience in the management of patients with deeply invasive bladder cancer.
    Skinner DG; Lieskovsky G
    Eur Urol; 1988; 14 Suppl 1():30-1. PubMed ID: 3181238
    [No Abstract]   [Full Text] [Related]  

  • 10. Bladder cancer treatment considerations for metastatic disease.
    Hahn RG
    Semin Oncol; 1979 Jun; 6(2):236-9. PubMed ID: 90388
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and management of deeply invasive and metastatic lesions.
    Whitmore WF
    Cancer Res; 1977 Aug; 37(8 Pt 2):2756-8. PubMed ID: 872102
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ conservation and reconstruction in advanced bladder cancer.
    Sternberg CN
    Prog Clin Biol Res; 1991; 370():131-42. PubMed ID: 1924442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endpoints of clinical trials for muscle-invasive bladder cancer.
    Tannock IF
    Prog Clin Biol Res; 1990; 353():65-74. PubMed ID: 2217428
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1).
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences.
    Startsev VY
    Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
    Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organ-preserving therapy in invasive bladder carcinoma].
    Dunst J; Bornhof C; Altendorf-Hofmann A; Wittekind C; Schrott KM; Sauer R
    Dtsch Med Wochenschr; 1992 Nov; 117(47):1783-8. PubMed ID: 1425303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.